Charlie Health vs Hims & Hers
Side-by-side comparison of AI visibility scores, market position, and capabilities
Virtual intensive outpatient mental health treatment for adolescents and young adults, Bozeman MT, raised $55M+. Addresses crisis-level care gaps via virtual IOP.
About
Charlie Health is a Bozeman, Montana-based virtual mental health company founded in 2020 that provides intensive outpatient program (IOP) care for adolescents, young adults, and families experiencing mental health crises. The company has raised over $55 million and targets the significant care gap between inpatient psychiatric hospitalization and standard outpatient therapy — a level of care that has historically been difficult to access, particularly outside major urban centers.\n\nCharlie Health's virtual IOP model delivers nine or more hours of structured group and individual therapy per week through a telehealth platform, allowing clients to receive high-intensity care from home while maintaining school or work routines. The clinical approach combines dialectical behavior therapy (DBT), cognitive behavioral therapy (CBT), and trauma-informed care, with treatment teams including licensed therapists, psychiatrists, and care coordinators. Programs are designed for adolescents aged 11 to 17 and young adults aged 18 to 26 presenting with depression, anxiety, trauma, self-harm, and suicidality.\n\nThe company accepts insurance from most major carriers, a deliberate strategic choice to reach underserved populations who cannot afford self-pay intensive treatment. Charlie Health's telehealth delivery model gives it geographic reach into rural and suburban communities where brick-and-mortar IOPs are scarce, positioning the company as an infrastructure solution for the adolescent mental health crisis that intensified during the COVID-19 pandemic.
Consumer telehealth platform with Q3 2025 revenue of $599M (+49% YoY); 2.47M subscribers; 2025 guidance $2.3-2.4B; acquiring ZAVA for European expansion; GLP-1 weight loss, hair, and sexual health treatments shipped directly to subscribers.
About
Hims & Hers is a consumer telehealth and pharmacy platform founded in 2017 in San Francisco by Andrew Dudum, built on the mission of making high-quality healthcare affordable and stigma-free for conditions that people historically avoided treating due to embarrassment, cost, or access barriers. The platform's core technology combines a direct-to-consumer digital health interface with an integrated pharmacy network, enabling patients to complete asynchronous or synchronous consultations with licensed clinicians and receive prescription treatments — including compounded medications — delivered directly to their homes.\n\nHims & Hers serves patients across sexual health, hair loss, mental health, dermatology, and weight management. The company's expansion into GLP-1 compounded weight loss medications has been a significant growth catalyst, capitalizing on surging consumer demand for semaglutide and tirzepatide alternatives during periods of branded drug shortages. With 2.47 million subscribers and a subscription-centric business model, the platform generates predictable recurring revenue from patients on ongoing treatment protocols. The company's 2025 acquisition of ZAVA expands its addressable market into European telehealth markets.\n\nHims & Hers reported Q3 revenue of $599 million, a 49% year-over-year increase, and issued full-year 2025 guidance of $2.3 to $2.4 billion — a scale that makes it one of the largest consumer telehealth companies in the world. The company's ability to compound subscriber growth with expanding treatment categories and international expansion through ZAVA provides multiple vectors for continued revenue acceleration. As healthcare consumerization intensifies and patients increasingly manage chronic conditions through digital-first platforms, Hims & Hers' brand recognition, integrated pharmacy infrastructure, and subscription model give it a durable position in consumer health.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.